Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Iron Deficiency Anemia in Childern With Liver Cirrhosis (IDA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03482076
Recruitment Status : Not yet recruiting
First Posted : March 29, 2018
Last Update Posted : March 29, 2018
Sponsor:
Information provided by (Responsible Party):
Bahaa Khaled Mohamed Mohamed, Assiut University

Brief Summary:
Iron deficiency anemia is a common complication of liver cirrhosis in childern and may affects there life this study to improve the outcome of these patients

Condition or disease Intervention/treatment Phase
Iron Deficiency, Anaemia in Children Liver Cirrhosis Diagnostic Test: transferrin receptor concentration Not Applicable

Detailed Description:
Patients with cirrhosis are at risk of developing both IDA and anemia of chronic disease concomitantly, and there adverse effects can deteriorate general condition and affect of quality of life in these patients .Also because it is easier to correct IDA than anemia of chronic disease, so this study of the prevalence of IDA helping us in the diagnosis and treatment of IDA and can reduce the need for other diagnostic tests and improve the quality of life in patients with cirrhosis .

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Prevelance of Iron Deficiency Anemia in Liver Cirrhosis in Childern
Estimated Study Start Date : March 1, 2019
Estimated Primary Completion Date : March 1, 2020
Estimated Study Completion Date : June 1, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anemia Cirrhosis Iron

Arm Intervention/treatment
transferrin receptor concentration
Prevelance of iron deficiency in this patients
Diagnostic Test: transferrin receptor concentration
Sandwich radio-imunoassay




Primary Outcome Measures :
  1. Prevelance of IDA in liver cirrhosis [ Time Frame: two years ]
    To evaluate results



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   1 Month to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • all childern with liver cirrhosis in GIT and hepatology unit

Exclusion Criteria:

  • Neonates less than one month
  • childern with other liver diseases

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03482076


Contacts
Layout table for location contacts
Contact: Bahaa Khaled Mohamed +201002755105 ext 002 drbahaakhaled@gmail.com
Contact: Nagla Hassan Ibrahim

Sponsors and Collaborators
Assiut University

Layout table for additonal information
Responsible Party: Bahaa Khaled Mohamed Mohamed, assistant lecturer, Assiut University
ClinicalTrials.gov Identifier: NCT03482076    
Other Study ID Numbers: DBK
First Posted: March 29, 2018    Key Record Dates
Last Update Posted: March 29, 2018
Last Verified: March 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Liver Cirrhosis
Anemia
Anemia, Iron-Deficiency
Fibrosis
Hematologic Diseases
Pathologic Processes
Liver Diseases
Digestive System Diseases
Anemia, Hypochromic
Iron Metabolism Disorders
Metabolic Diseases